secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0000950170-24-017174
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome Therapeutics updates corporate presentation on February 20, 2024
-----------------------------------------------------------------------

- Company posted updated corporate presentation to its website on February 20, 2024.
- Presentation filed as Exhibit 99.1; specific content not available in filing text.
- No financial results, clinical updates, or guidance changes disclosed in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000095017024017174/0000950170-24-017174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000095017024017174/axsm-20240220.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-017174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer